Selenium Associations with Hypertension and T2D: Gender Dependent Findings

Ronald Gross^*
*Correspondence: Ronald Gross, Department of Hypertension, University of Texas, Austin, TX 78712, USA, Email:

Keywords

Selenium associations • Hypertension • Research

Introduction

Selenium, a trace element essential for human health, has long been of interest to researchers for its potential impact on various aspects of well-being. In a recent study involving 1500 senior subjects from the Berlin Aging Study II, scientists have unearthed a fascinating revelation: the element selenium exhibits a U-shaped association with hypertension in men. This discovery not only underscores the intricate relationship between micronutrients and cardiovascular health but also calls for a closer examination of the factors influencing selenium's effects on hypertension. The Berlin Aging Study II (BASE-II) is an extensive investigation of aging, involving over 1500 participants aged 60 to 84 years. This diverse cohort has allowed scientists to explore various aspects of aging, health, and disease risk.

Literature Review

Selenium is a micronutrient known for its antioxidant properties and its crucial role in various biological processes. While selenium is essential for human health, its levels in the body must be carefully balanced. The most intriguing revelation from this study is the U-shaped relationship observed between selenium and hypertension in senior men. This means that both low and high selenium levels may be associated with an increased risk of hypertension, with the optimal range residing in the middle. Hypertension, or high blood pressure, is a significant risk factor for cardiovascular diseases, making this finding particularly noteworthy. Understanding how selenium influences blood pressure regulation may provide valuable insights into hypertension prevention and management [1].

The U-shaped association with hypertension underscores the need for personalized healthcare. Individual selenium levels, lifestyle factors, and other variables should be considered when assessing cardiovascular risk in senior men. Achieving an optimal selenium balance is crucial. While selenium deficiency can be detrimental to health, excessive selenium intake can also lead to health issues. Achieving the right balance is the key to reaping the micronutrient's benefits. The BASE-II study opens the door to further research into the complex relationship between selenium and hypertension. Investigating the mechanisms that underlie this U-shaped association may reveal new avenues for hypertension prevention and treatment.

Discussion

The finding of a U-shaped association between selenium and hypertension in senior men within the Berlin Aging Study II is a fascinating addition to the field of cardiovascular health. It reminds us that even essential micronutrients like selenium can have complex and nuanced effects on the body. As we continue to explore these relationships, we move closer to more personalized and effective approaches to hypertension management, particularly in senior populations where the impact of hypertension is most significant. This study serves as a crucial building block in our ongoing quest for healthier aging and enhanced quality of life [2].

Selenium, an essential trace element, is known for its critical role in various physiological processes. Recent research has revealed a noteworthy association between SELENOP (Selenoprotein P), selenium, and two common health concerns: hypertension and Type 2 diabetes (T2D). Surprisingly, SELENOP exhibits a dose-dependent relationship with these conditions, with distinct outcomes for men and women. This article explores the intricate link between SELENOP, hypertension, and T2D and its potential implications for personalized healthcare. Selenoprotein P, or SELENOP, is a fascinating molecule that acts as a selenium transporter within the human body. It plays a pivotal role in delivering selenium to tissues and cells, ensuring their proper function [3].

Selenium is an essential micronutrient with antioxidant properties, and its role in human health is multifaceted. However, the relationship between SELENOP, selenium, and specific health conditions is not yet fully understood. The research demonstrates that SELENOP displays a dose-dependent association with hypertension in women. This means that the level of SELENOP in the body correlates with the risk of developing hypertension. Hypertension, or high blood pressure, is a significant risk factor for heart disease and stroke. Understanding the link between SELENOP and hypertension is a crucial step toward identifying individuals at higher risk and developing targeted prevention and management strategies Interestingly, the study reveals distinct genderspecific outcomes.

In men, SELENOP exhibits a dose-dependent association with Type 2 diabetes (T2D). This indicates that higher levels of SELENOP are linked to an increased risk of developing T2D [4]. T2D is a metabolic disorder characterized by insulin resistance and high blood sugar levels. This newfound connection between SELENOP and T2D in men prompts further investigation into the molecular mechanisms involved. The study's findings highlight the importance of gender-specific healthcare. Understanding how SELENOP affects men and women differently allows for more personalized healthcare approaches. Given selenium's essential role in health, the findings may have implications for selenium intake recommendations [5,6].

Conclusion

Balancing selenium levels to optimize health may be a key consideration. This research opens the door to further exploration of SELENOP's precise mechanisms in hypertension and T2D development. In the future, these insights may lead to more targeted interventions and therapies. The relationship between SELENOP, selenium, hypertension, and Type 2 diabetes is a fascinating area of study with far-reaching implications for public health. These findings underscore the complexity of human physiology and the importance of gender-specific healthcare approaches. As research continues to unveil the intricacies of this relationship, we move closer to more personalized healthcare strategies, allowing for more effective prevention and management of hypertension and T2D, two health conditions of global concern.

Acknowledgement

None.

Conflict of Interest

None

References

1. Van Sloten, Thomas T and Coen DA Stehouwer. "Carotid stiffness: A novel cerebrovascular disease risk factor." Pulse 41(2016): 24-27.

   Google Scholar, Crossref, Indexed at

2. Santos, Cláudia Y, Peter J Snyder, Wen-Chih Wu and Mia Zhang, et al. "Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease and cardiovascular risk: A review and synthesis." DADM 7 (2017): 69-87.

   Google Scholar, Crossref, Indexed at

3. Hankey, Graeme J, Charles P Warlow and Robin J Sellar. "Cerebral angiographic risk in mild cerebrovascular disease." Stroke 21 (1990): 209-222.

   Google Scholar, Crossref, Indexed at

4. Smith, Grace L, Benjamin D Smith, Thomas A Buchholz and Sharon H Giordano, et al. "Cerebrovascular disease risk in older head and neck cancer patients after radiotherapy." Clin Oncol 26 (2008): 5119.

   Google Scholar, Crossref, Indexed at

5. Brattstrom, L. E., J. E. Hardebo and B. L. Hultberg. "Moderate homocysteinemia--a possible risk factor for arteriosclerotic cerebrovascular disease." Stroke 15 (1984): 1012-1016.

   Google Scholar, Crossref, Indexed at

6. Olivares, Reyes, J Alberto, Marina Macı́as Silva and J Adolfo Garcıa Sainz. "Atypical angiotensin II receptors coupled to phosphoinositide turnover/calcium signalling in catfish hepatocytes." Biochim Biophys Acta Mol Cell Res 1357 (1997): 201-208.

   Google Scholar, Crossref, Indexed at